Symbiotic Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
AiM Medical Robotics develops a portable, MRI-compatible surgical robot for neurosurgical procedures performed in the MRI suite and operating room, aimed at improving precision and automation for treating functional brain disorders (such as Parkinson's and epilepsy) and cancer.
HealthtechMedical DevicesRoboticsWorcester, US
Gregory Fischer(CEO/President, Founder & Co-inventor)inJulie G. Pilitsis(Chair of Medical Advisory Board, Founder & Co-Inventor)Andrew Aberdale(President & Chief Financial Officer)inRachel LeBlanc(Chief Operations Officer & Board Secretary)inCraig Pierson(Director, Promoter)in
BoardRobert Cathcart(Chairman)
Co-investorsIQ Capital
Pixion develops a patented dry electrode processing technology for lithium-ion battery production, aimed at lowering costs, reducing factory footprints, and improving cell performance.
CleantechEnergyNew MaterialsAustin, US
Vikram Devaraj(Executive Officer, Director)Varun Devaraj(Executive Officer, Director)
BoardWilliam Clark(Director)
Co-investorsCentral Texas Angel Network
SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish.
AgTechBiotechHealthtechImpact & Social GoodMadison, US
Thomas D'Orazio(Executive Officer, Director)inMark Fraker(VP – Operations)inUrsula Bechert(VP – Research & Development)inTom(CEO)Tina(Chief Operating Officer)in
BoardJeffrey Rusinow(Director)
Co-investorsCentral Texas Angel NetworkSerra Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





.jpeg)



